Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Study of Metronomic Temozolomide With Dexbrompheniramine for Patients With Recurrent High-Grade Glioma/Glioblastoma

NCT07859059 is registered in ClinicalTrials.gov with University of Nebraska as lead sponsor.

NCT NCT07859059
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07859059 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Study of Metronomic Temozolomide With Dexbrompheniramine for Patients With Recurrent High-Grade Glioma/Glioblastoma
Lead sponsor
University of Nebraska
Phase
Phase 1/2
Overall status
Not yet recruiting
Start date
June 1, 2027
Completion date
June 1, 2031
Enrollment
41 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma, gliosarcoma, high grade glioma